CL2017000555A1 - Vacuna multivalente de brucella para la proteccion contra infecciones micobacterianas y metodos para su uso. - Google Patents

Vacuna multivalente de brucella para la proteccion contra infecciones micobacterianas y metodos para su uso.

Info

Publication number
CL2017000555A1
CL2017000555A1 CL2017000555A CL2017000555A CL2017000555A1 CL 2017000555 A1 CL2017000555 A1 CL 2017000555A1 CL 2017000555 A CL2017000555 A CL 2017000555A CL 2017000555 A CL2017000555 A CL 2017000555A CL 2017000555 A1 CL2017000555 A1 CL 2017000555A1
Authority
CL
Chile
Prior art keywords
multivalent
brucella
protection against
methods
vaccine
Prior art date
Application number
CL2017000555A
Other languages
English (en)
Inventor
Sriranganathan Nammalwar
Qublan Hamzeh Al
Garrett Smith
Stephen Boyle
Gerhardt Schurig
Original Assignee
Virginia Tech Intellectual Properties Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virginia Tech Intellectual Properties Inc filed Critical Virginia Tech Intellectual Properties Inc
Publication of CL2017000555A1 publication Critical patent/CL2017000555A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Provided herein is a multivalent Brucella vaccine expressing at least one heterologous M. tuberculosis antigen. The vaccines described herein serve as an environmentally safe bivalent vaccine for protection against Brucella and Mycobacterium infections simultaneously. In particular, a multivalent vaccine comprising a Brucella strain transformed with a vector that expresses at least one M. tuberculosis antigen, where the M. tuberculosis antigen(s) is codon optimized for the Brucella strain is provided. In
CL2017000555A 2014-09-09 2017-03-08 Vacuna multivalente de brucella para la proteccion contra infecciones micobacterianas y metodos para su uso. CL2017000555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462047945P 2014-09-09 2014-09-09

Publications (1)

Publication Number Publication Date
CL2017000555A1 true CL2017000555A1 (es) 2018-04-06

Family

ID=55459461

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000555A CL2017000555A1 (es) 2014-09-09 2017-03-08 Vacuna multivalente de brucella para la proteccion contra infecciones micobacterianas y metodos para su uso.

Country Status (6)

Country Link
US (1) US10406219B2 (es)
EP (1) EP3191580A4 (es)
BR (1) BR112017004576A2 (es)
CL (1) CL2017000555A1 (es)
MX (1) MX2017003017A (es)
WO (1) WO2016040258A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6333814B2 (ja) * 2012-07-10 2018-05-30 トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． マイコバクテリア抗原ワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis

Also Published As

Publication number Publication date
BR112017004576A2 (pt) 2018-05-02
US20170246282A1 (en) 2017-08-31
EP3191580A1 (en) 2017-07-19
MX2017003017A (es) 2018-02-19
US10406219B2 (en) 2019-09-10
WO2016040258A1 (en) 2016-03-17
EP3191580A4 (en) 2018-02-28

Similar Documents

Publication Publication Date Title
MX2021000285A (es) Composiciones que comprenden cepas bacterianas.
EP3012322A4 (en) GENEELED STRAIN VARIANT OF PORCINE PSEUDORABIES VIRUS, VACCINE COMPOSITION, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF
EP3200831A4 (en) Vaccines having an antigen and interleukin-21 as an adjuvant
EP3200823A4 (en) Multivalent meditopes, meditope-binding antibodies and uses thereof
BR112015032254A2 (pt) sistema para uso em um poço submarino, sistema para uso em um poço, e método.
BR112016017402A2 (pt) fusões anti-pcsk9~glp-1 e métodos para uso
EP3435236A4 (en) PROTOCOL COLLECTING DEVICE, LOG PRODUCING DEVICE AND PROTOCOL COLLECTING METHOD
CL2016002402A1 (es) Composiciones inmunológicas que contiene histophilus somni atenuado
EP3385286A4 (en) ANTIGEN VACCINE WITH INCREASED IMMUNOGENICITY
EP3416681A4 (en) NOVEL ANTIGEN FOR USE IN ANTI-MALARIA VACCINE
CL2016003107A1 (es) Vacunas guiadas por anticuerpos y métodos de uso para generar respuestas inmunitarias maduras rápidas
MX2022013912A (es) Procedimientos novedosos para inducir una respuesta inmunitaria.
IL252644A0 (en) Vaccines based on jaundice core antigens b
MA43517A (fr) Vaccin multivalent contre m. hyo et ses utilisations
AR089995A1 (es) Vacunas de subunidades de rotavirus, metodos de preparacion y uso de las mismas
CL2018000513A1 (es) Vacunas de pestivirus para temblores congénitos
EP3104887A4 (en) Vaccines with interleukin-17 as an adjuvant
EP4226936A3 (en) Non-neuroinvasive viruses and uses thereof
MX2019008779A (es) Antigenos de pseudomonas y combinaciones de antigenos.
SG11201610200RA (en) Method for producing tolerogenic dendritic cells with specific antigens and uses thereof
CL2017000555A1 (es) Vacuna multivalente de brucella para la proteccion contra infecciones micobacterianas y metodos para su uso.
IL247295A0 (en) Components based on antigens with a yellow core b
ZA201701972B (en) Method for preparing a vaccine antigen, resulting vaccine antigen and uses
WO2014198913A3 (en) Novel piscirickettsia salmonis isolate
WO2018046955A3 (en) Francisella glycoconjugate vaccines